SCHEMBL22014403

SCHEMBL22014403

Cc1c(-c2ccccc2)cc(F)cc1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.38
PTGS1 P23219 4/20 0.37
MEN1 O00255 2/20 0.37
PTGS2 P35354 2/20 0.37
KMT2A Q03164 2/20 0.37
FABP2 P12104 1/20 0.37
TSHR P16473 1/20 0.37
AKR1C4 P17516 1/20 0.37
ADRA2B P18089 1/20 0.37
CHRM3 P20309 1/20 0.37
HTR2C P28335 1/20 0.37
DRD3 P35462 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15856377 0.82 METAP2 (0.46) METAP2PTGS1MEN1PTGS2KMT2A
SCHEMBL20754892 0.81 METAP2 (0.37) METAP2PTGS1MEN1PTGS2KMT2A
SCHEMBL20912008 0.78 ALDH1A1 (0.43) METAP2PTGS1MEN1PTGS2KMT2A
SCHEMBL23419417 0.78 PTGS1 (0.39) METAP2PTGS1MEN1PTGS2KMT2A
SCHEMBL23046908 0.77 PTGS1 (0.42) METAP2PTGS1MEN1PTGS2KMT2A
SCHEMBL20634961 0.76 CA1 (0.35) LMNA
SCHEMBL22374010 0.76 CCNC (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20754729 0.73 PTGS1 (0.35) METAP2PTGS1MEN1PTGS2KMT2A
SCHEMBL21962584 0.73 NLRP3 (0.42) PTGS1MEN1PTGS2KMT2AFABP2
SCHEMBL30933569 0.73 ESR2 (0.42) METAP2PTGS1MEN1PTGS2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed